atrial appendage Search Results


percutaneous laa trans-catheter occlusion plaato  (Appriva Medical Inc)
90
Appriva Medical Inc percutaneous laa trans-catheter occlusion plaato
Pre-surgery echo of <t>left</t> <t>atrial</t> <t>appendage</t>
Percutaneous Laa Trans Catheter Occlusion Plaato, supplied by Appriva Medical Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/percutaneous laa trans-catheter occlusion plaato/product/Appriva Medical Inc
Average 90 stars, based on 1 article reviews
percutaneous laa trans-catheter occlusion plaato - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
watchman left atrial appendage closure device  (Boston Scientific Corporation)
90
Boston Scientific Corporation watchman left atrial appendage closure device
Pre-surgery echo of <t>left</t> <t>atrial</t> <t>appendage</t>
Watchman Left Atrial Appendage Closure Device, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/watchman left atrial appendage closure device/product/Boston Scientific Corporation
Average 90 stars, based on 1 article reviews
watchman left atrial appendage closure device - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
modified occlutech laa closure device  (Occlutech GmbH)
90
Occlutech GmbH modified occlutech laa closure device
Occlutech Plus <t>LAA</t> closure device and delivery system. (A) <t>The</t> <t>modified</t> Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.
Modified Occlutech Laa Closure Device, supplied by Occlutech GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/modified occlutech laa closure device/product/Occlutech GmbH
Average 90 stars, based on 1 article reviews
modified occlutech laa closure device - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
right atrial appendages  (Herzzentrum Dresden)
90
Herzzentrum Dresden right atrial appendages
Occlutech Plus <t>LAA</t> closure device and delivery system. (A) <t>The</t> <t>modified</t> Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.
Right Atrial Appendages, supplied by Herzzentrum Dresden, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/right atrial appendages/product/Herzzentrum Dresden
Average 90 stars, based on 1 article reviews
right atrial appendages - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
left atrial appendage clip atriclip  (AtriCure Inc)
90
AtriCure Inc left atrial appendage clip atriclip
Occlutech Plus <t>LAA</t> closure device and delivery system. (A) <t>The</t> <t>modified</t> Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.
Left Atrial Appendage Clip Atriclip, supplied by AtriCure Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/left atrial appendage clip atriclip/product/AtriCure Inc
Average 90 stars, based on 1 article reviews
left atrial appendage clip atriclip - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
wavecrest® left atrial appendage occlusion system  (Coherex Medical Inc)
90
Coherex Medical Inc wavecrest® left atrial appendage occlusion system
Occlutech Plus <t>LAA</t> closure device and delivery system. (A) <t>The</t> <t>modified</t> Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.
Wavecrest® Left Atrial Appendage Occlusion System, supplied by Coherex Medical Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wavecrest® left atrial appendage occlusion system/product/Coherex Medical Inc
Average 90 stars, based on 1 article reviews
wavecrest® left atrial appendage occlusion system - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
left atrial appendage occluder  (Occlutech GmbH)
90
Occlutech GmbH left atrial appendage occluder
Stepwise embolization with coils of the arteriovenous communication using the stable position of the patent ductus arteriosus/left <t>atrial</t> <t>appendage</t> occluders for an anchoring maneuver to avoid distal coil migration. Note the attenuation of the contrast intensity in the inferior vena cava.
Left Atrial Appendage Occluder, supplied by Occlutech GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/left atrial appendage occluder/product/Occlutech GmbH
Average 90 stars, based on 1 article reviews
left atrial appendage occluder - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
device for left atrial appendage closure  (AtriCure Inc)
90
AtriCure Inc device for left atrial appendage closure
Stepwise embolization with coils of the arteriovenous communication using the stable position of the patent ductus arteriosus/left <t>atrial</t> <t>appendage</t> occluders for an anchoring maneuver to avoid distal coil migration. Note the attenuation of the contrast intensity in the inferior vena cava.
Device For Left Atrial Appendage Closure, supplied by AtriCure Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/device for left atrial appendage closure/product/AtriCure Inc
Average 90 stars, based on 1 article reviews
device for left atrial appendage closure - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
left atrial appendage exclusion for prophylactic stroke reduction trial (leaaps)  (AtriCure Inc)
90
AtriCure Inc left atrial appendage exclusion for prophylactic stroke reduction trial (leaaps)
Stepwise embolization with coils of the arteriovenous communication using the stable position of the patent ductus arteriosus/left <t>atrial</t> <t>appendage</t> occluders for an anchoring maneuver to avoid distal coil migration. Note the attenuation of the contrast intensity in the inferior vena cava.
Left Atrial Appendage Exclusion For Prophylactic Stroke Reduction Trial (Leaaps), supplied by AtriCure Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/left atrial appendage exclusion for prophylactic stroke reduction trial (leaaps)/product/AtriCure Inc
Average 90 stars, based on 1 article reviews
left atrial appendage exclusion for prophylactic stroke reduction trial (leaaps) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
amplatzertm amulettm left atrial appendage occluder  (St Jude Medical)
90
St Jude Medical amplatzertm amulettm left atrial appendage occluder
Stepwise embolization with coils of the arteriovenous communication using the stable position of the patent ductus arteriosus/left <t>atrial</t> <t>appendage</t> occluders for an anchoring maneuver to avoid distal coil migration. Note the attenuation of the contrast intensity in the inferior vena cava.
Amplatzertm Amulettm Left Atrial Appendage Occluder, supplied by St Jude Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amplatzertm amulettm left atrial appendage occluder/product/St Jude Medical
Average 90 stars, based on 1 article reviews
amplatzertm amulettm left atrial appendage occluder - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
percutaneous left atrial appendage transcatheter occlusion (plaato) device  (ev3 Endovascular)
90
ev3 Endovascular percutaneous left atrial appendage transcatheter occlusion (plaato) device
( A ) Watchman, ( B ) Watchman FLX, ( C ) fluoroscopic image of the Watchman, ( D ) TEE image showing a deployed Watchman, ( E ) Amplatzer Cardiac Plug (ACP), ( F ) Amulet, ( G ) Fluoroscopic image of the ACP device, ( H ) transesophageal echocardiogram image showing a deployed Amulet device, ( I ) <t>PLAATO,</t> ( J ) WaveCrest, ( K ) Occlutech, ( L ) LAmbre, ( M ) Sideris Patch, ( N ) Ultraseal, ( O ) Pfm, ( P ) LARIAT, ( Q ) Sierra Ligation System. Reprinted from Asmarats and Rodés‐Cabau <xref ref-type= 74 with permission. Copyright ©2017 American Heart Association, Inc. ACP indicates Amplatzer Cardiac Plug; and PLAATO, percutaneous left atrial appendage transcatheter occlusion. " width="250" height="auto" />
Percutaneous Left Atrial Appendage Transcatheter Occlusion (Plaato) Device, supplied by ev3 Endovascular, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/percutaneous left atrial appendage transcatheter occlusion (plaato) device/product/ev3 Endovascular
Average 90 stars, based on 1 article reviews
percutaneous left atrial appendage transcatheter occlusion (plaato) device - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
atriclip® left atrial appendage exclusion system  (AtriCure Inc)
90
AtriCure Inc atriclip® left atrial appendage exclusion system
( A ) Watchman, ( B ) Watchman FLX, ( C ) fluoroscopic image of the Watchman, ( D ) TEE image showing a deployed Watchman, ( E ) Amplatzer Cardiac Plug (ACP), ( F ) Amulet, ( G ) Fluoroscopic image of the ACP device, ( H ) transesophageal echocardiogram image showing a deployed Amulet device, ( I ) <t>PLAATO,</t> ( J ) WaveCrest, ( K ) Occlutech, ( L ) LAmbre, ( M ) Sideris Patch, ( N ) Ultraseal, ( O ) Pfm, ( P ) LARIAT, ( Q ) Sierra Ligation System. Reprinted from Asmarats and Rodés‐Cabau <xref ref-type= 74 with permission. Copyright ©2017 American Heart Association, Inc. ACP indicates Amplatzer Cardiac Plug; and PLAATO, percutaneous left atrial appendage transcatheter occlusion. " width="250" height="auto" />
Atriclip® Left Atrial Appendage Exclusion System, supplied by AtriCure Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/atriclip® left atrial appendage exclusion system/product/AtriCure Inc
Average 90 stars, based on 1 article reviews
atriclip® left atrial appendage exclusion system - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Pre-surgery echo of left atrial appendage

Journal: International Journal of Preventive Medicine

Article Title: Left Atrial Appendage Occlusion

doi:

Figure Lengend Snippet: Pre-surgery echo of left atrial appendage

Article Snippet: Recently, two devices specifically designed for percutaneous trans-catheter LAA occlusion have been introduced: the percutaneous LAA trans-catheter occlusion (PLAATO; Appriva Medical Inc) and WATCHMAN LAA system (Atritech, Inc).

Techniques:

Post-surgery echo of left atrial appendage

Journal: International Journal of Preventive Medicine

Article Title: Left Atrial Appendage Occlusion

doi:

Figure Lengend Snippet: Post-surgery echo of left atrial appendage

Article Snippet: Recently, two devices specifically designed for percutaneous trans-catheter LAA occlusion have been introduced: the percutaneous LAA trans-catheter occlusion (PLAATO; Appriva Medical Inc) and WATCHMAN LAA system (Atritech, Inc).

Techniques:

Occlutech Plus LAA closure device and delivery system. (A) The modified Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.

Journal: Scientific Reports

Article Title: Preclinical assessment of a modified Occlutech left atrial appendage closure device in a porcine model

doi: 10.1038/s41598-021-82359-1

Figure Lengend Snippet: Occlutech Plus LAA closure device and delivery system. (A) The modified Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.

Article Snippet: The results of this study indicate that implantation of a modified Occlutech LAA closure device is feasible with rapid endothelialization and low inflammatory infiltration in a porcine model. Human data are needed to further characterize safety and efficacy.

Techniques: Modification

Technical properties of LAA closure during follow-up.

Journal: Scientific Reports

Article Title: Preclinical assessment of a modified Occlutech left atrial appendage closure device in a porcine model

doi: 10.1038/s41598-021-82359-1

Figure Lengend Snippet: Technical properties of LAA closure during follow-up.

Article Snippet: The results of this study indicate that implantation of a modified Occlutech LAA closure device is feasible with rapid endothelialization and low inflammatory infiltration in a porcine model. Human data are needed to further characterize safety and efficacy.

Techniques: Coagulation

Stepwise embolization with coils of the arteriovenous communication using the stable position of the patent ductus arteriosus/left atrial appendage occluders for an anchoring maneuver to avoid distal coil migration. Note the attenuation of the contrast intensity in the inferior vena cava.

Journal: Methodist DeBakey Cardiovascular Journal

Article Title: Uneventful Follow-Up 2 Years after Endovascular Treatment of a High-Flow Iatrogenic Aortocaval Fistula Causing Pulmonary Hypertension and Right Heart Failure

doi: 10.14797/mdcj-15-2-152

Figure Lengend Snippet: Stepwise embolization with coils of the arteriovenous communication using the stable position of the patent ductus arteriosus/left atrial appendage occluders for an anchoring maneuver to avoid distal coil migration. Note the attenuation of the contrast intensity in the inferior vena cava.

Article Snippet: As a first step, we implanted two devices—a left atrial appendage (LAA) and patent ductus arteriosus (PDA) occluder (Occlutech International, AB)—in the ostium of the right renal artery ( ).

Techniques: Migration

( A ) Watchman, ( B ) Watchman FLX, ( C ) fluoroscopic image of the Watchman, ( D ) TEE image showing a deployed Watchman, ( E ) Amplatzer Cardiac Plug (ACP), ( F ) Amulet, ( G ) Fluoroscopic image of the ACP device, ( H ) transesophageal echocardiogram image showing a deployed Amulet device, ( I ) PLAATO, ( J ) WaveCrest, ( K ) Occlutech, ( L ) LAmbre, ( M ) Sideris Patch, ( N ) Ultraseal, ( O ) Pfm, ( P ) LARIAT, ( Q ) Sierra Ligation System. Reprinted from Asmarats and Rodés‐Cabau <xref ref-type= 74 with permission. Copyright ©2017 American Heart Association, Inc. ACP indicates Amplatzer Cardiac Plug; and PLAATO, percutaneous left atrial appendage transcatheter occlusion. " width="100%" height="100%">

Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Article Title: Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation

doi: 10.1161/JAHA.121.022274

Figure Lengend Snippet: ( A ) Watchman, ( B ) Watchman FLX, ( C ) fluoroscopic image of the Watchman, ( D ) TEE image showing a deployed Watchman, ( E ) Amplatzer Cardiac Plug (ACP), ( F ) Amulet, ( G ) Fluoroscopic image of the ACP device, ( H ) transesophageal echocardiogram image showing a deployed Amulet device, ( I ) PLAATO, ( J ) WaveCrest, ( K ) Occlutech, ( L ) LAmbre, ( M ) Sideris Patch, ( N ) Ultraseal, ( O ) Pfm, ( P ) LARIAT, ( Q ) Sierra Ligation System. Reprinted from Asmarats and Rodés‐Cabau 74 with permission. Copyright ©2017 American Heart Association, Inc. ACP indicates Amplatzer Cardiac Plug; and PLAATO, percutaneous left atrial appendage transcatheter occlusion.

Article Snippet: The first percutaneous LAAO device implanted in humans was the Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO) device (ev3 endovascular, Plymouth, MN) (Figure ).

Techniques: Ligation

AF indicates atrial fibrillation; ASAP, ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology; ASAP TOO, The Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation; CAP, Continued Access to PROTECT AF; CAP2, Continued Access to PREVAIL; CE, conformité européenne; EXCLUDE, Exclusion of Left Atrial Appendage with AtriClip Exclusion Device in Patients Undergoing Concomitant Cardiac Surgery; FDA, Food and Drug Administration; LAA, left atrial appendage; LAAOS I, Left Atrial Appendage Occlusion During Cardiac Surgery to Prevent Stroke; and PLAATO, percutaneous left atrial appendage transcatheter occlusion.

Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Article Title: Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation

doi: 10.1161/JAHA.121.022274

Figure Lengend Snippet: AF indicates atrial fibrillation; ASAP, ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology; ASAP TOO, The Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation; CAP, Continued Access to PROTECT AF; CAP2, Continued Access to PREVAIL; CE, conformité européenne; EXCLUDE, Exclusion of Left Atrial Appendage with AtriClip Exclusion Device in Patients Undergoing Concomitant Cardiac Surgery; FDA, Food and Drug Administration; LAA, left atrial appendage; LAAOS I, Left Atrial Appendage Occlusion During Cardiac Surgery to Prevent Stroke; and PLAATO, percutaneous left atrial appendage transcatheter occlusion.

Article Snippet: The first percutaneous LAAO device implanted in humans was the Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO) device (ev3 endovascular, Plymouth, MN) (Figure ).

Techniques: